Transcenta Holding Limited

HK$0.76As of Sun 8 Nov 2026, 12:00 UTC
HKEX:6628Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 5Y CAGR (44.94%)
Div yield —
ROE (26.76%)
Biotechnology
Beta (5Y) (0.44)
PE TTM —
TSR TTM (75.24%)
Mkt cap HK$324.5M
ROIC (11.96%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.976
28.37%
(6.54%)
Hold 1|1|7|1|1
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.01
0.01
0.01
0.01
11.28%
(0.93%)
2.90%
9.36%
Revenue¥M
35.46
36.10
37.35
37.72
1.90%
6.73%
13.57%
10.63%
Peers (US$41.39M)
Cap (US$)
PE
31.89M
—
Capital
TTM
5Y
10Y
Leveragex
1.002
(0.145)
(0.101)
EBIT/Intx
0.092
0.431
0.436
Own earn%
(19.41)
27.43
3.12
Sh yield%
35.07
28.40
32.75
Owners
Insiders/Inst%
14.75
36.51
Short interest%
5.17
SBC / revenue%
5.10
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
17–22
$1 testx
−0.8
Incr. ROIC%
6